| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3437799 | American Journal of Obstetrics and Gynecology | 2009 | 7 Pages |
Abstract
The lower incidence of gynecologic adverse events and interventions with anastrozole and the early occurrence of these events provide further support for using anastrozole as the initial adjuvant treatment for early hormone receptor-positive breast cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Sean R. MD, Wolfgang MD, Anthony MD, Jack PhD, Michael MD,